K Line’s LNG carrier fleet to rise to 65 vessels by fiscal 2026, CEO says

Japan's shipping giant K Line is on track with its plans to have 65 liquefied natural gas (LNG) carriers in its fleet by fiscal 2026, according to K Line's new CEO, Takenori Igarashi.

This story requires a subscription

Get 12 months of full digital access to LNG Prime for only $295 instead of $600.
This includes a single user license.
Check our FAQ for more info. For group subscriptions please contact us.

Most Popular

Crown LNG, Fermeuse plan export project in Canada

US-listed Crown LNG and Fermeuse Energy revealed plans to build a liquefaction and export facility worth up to $15 billion in the Canadian province of Newfoundland and Labrador.

Sawgrass LNG & Power secures Barbados supply deal

Miami-based Sawgrass LNG & Power has once again been selected as the supplier of LNG to Barbados National Energy Company (BNECL).

Woodfibre LNG says project cost climbs to $8.8 billion

Canada’s Woodfibre LNG, a joint venture of Pacific Energy and Enbridge, now expects that the construction of its 2.1 mtpa LNG export facility near Squamish, British Columbia, will cost $8.8 billion. Woodfibre LNG initially expected the construction of the facility would cost $5.1 billion.

More News Like This

NYK, partners take delivery of QatarEnergy LNG carrier

Japan’s NYK and its partners K Line, Malaysia’s MISC, and China’s CLNG have taken delivery of a 174,000-cbm LNG carrier built under the massive QatarEnergy shipbuilding program.

Singapore’s FueLNG in 500th STS bunkering operation

Singapore’s FueLNG, a joint venture consisting of Shell and Seatrium, has completed its 500th ship-to-ship (STS) LNG bunkering operation.

Another QatarEnergy LNG carrier named in China

Chinese shipbuilder Hudong-Zhonghua hosted a naming ceremony for another LNG carrier built under the massive QatarEnergy shipbuilding program.

QatarEnergy LNG tanker wraps up trials in China

A 174,000-cbm LNG carrier built as part of the massive QatarEnergy shipbuilding program has completed its trials in China, according to Hudong-Zhonghua.